Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1

AIDS

Volumn 19, Issue 8, 2005, Pages 775-784

  Troesch, Myriam ^a,c   Jalbert, Emilie ^a,b,c   Canobio, Sophie ^a,c   Boulassel, M Rachid ^d   Routy, Jean Pierre ^d   Bernard, Nicole F ^d   Bruneau, Julie ^e   Lapointe, Normand ^a,c   Boucher, Marc ^a,c   Soudeyns, Hugo ^a,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Alternate reading frame protein; Co infection; Crossreactivity; Cytotoxic T lymphocytes; Hepatitis C

Indexed keywords

EPITOPE; HLA A ANTIGEN; UNCLASSIFIED DRUG; VACCINIA VACCINE; VIRUS PROTEIN; VIRUS PROTEIN F;

ADULT; AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; CELL ACTIVITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CODING; CONTROLLED STUDY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; ESCHERICHIA COLI; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VIRUS CORE; VIRUS MUTATION;

EID: 20644463921     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000168971.57681.6e     Document Type: Article

References (37)

1. Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol 1995; 69:2462-2470.
2. Rehermann B, Chang KM, McHutchison JC, Kokka R, Houghton M, Chisari FV. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 1996; 98:1432-1440.
3. Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10:439-449.
4. Lechner F, Wong DKH, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 2000; 191:1499-1512.
5. Rehermann B. Interaction between the hepatitis C virus and the immune system. Semin Liver Dis 2000; 20:127-141.
6. Khakoo SI, Thio CL, Martin MP, Brooks CR, Cao X, Astemborski J, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305:872-874.
7. Laurence J. Potential roles for chemokine receptor CCR5 in the pathobiology of hepatitis C infection. Gastroenterology 2002; 122:2069-2080.
8. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997; 27:18-24.
9. Sulkowski MS, Mast EE, Seef LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000; 30 (Suppl. 1):S77-S84.
10. Cribier B, Rey D, Schmitt C, Lang JM, Kim A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS 1995; 9:1131-1136.
11. George SL, Gebhardt J, Klinzman D, Foster MB, Patrick KD, Schmidt WN, et al. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests. J Acquir Immune Defic Syndr 2002; 31:154-162.
12. Lauer CM, Nguyen TN, Day CL, Robbins CK, Flynn T, McCowan K, et al. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol 2002; 76:2817-2826.
13. Elliott T, Bodmer H, Townsend A. Recognition of out-of-frame major histocompatibility complex class I-restricted epitopes in vivo. Eur J Immunol 1996; 26:1175-1179.
14. Ronsin C, Chung-Scott V, Poullion I, Aknouche N, Caudin C, Triebel F. A non-AUG-defined alternative open reading frame of the intestinal carboxyl esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. J Immunol 1999; 163:483-490.
15. Smith DB, Simmonds P. Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol 1997; 45:238-246.
16. Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Covindarajan A, et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 2001; 20:3840-3848.
17. Walewski JL, Keller TR, Stump DD, Branch AD. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 2001; 7:710-721.
18. Cristina J, Lopez F, Moratorio C, Lopez L, Vasquez S, Carcia-Aguirre L, Chunga A. Hepatitis C virus F protein sequence reveals a lack of functional constraints and a variable pattern of amino acid substitution. J Gen Virol 2004; 86:115-120.
19. Basu A, Steele R, Ray R, Ray RB. Functional properties of a 16 kDa protein translated from an open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol 2004; 85:2299-2306.
20. Lo SY, Selby M, Tong M, Ou JH. Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino-acid substitution. Virology 1994; 199:124-131.
21. Bain C, Parroche P, Lavergne JP, Duverger B, Vieux C, Dubois V, et al. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Vitol 2004; 78:10460-10469.
22. Komurian-Pradel F, Rajoharison A, Berland JL, Khouri V, Perret M, van Roosmalen M, et al. Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 2004; 40:900-909.
23. Murphy D, Willems B, Delage C. Use of the 5′ noncoding region for genotyping hepatitis C virus. J Infect Dis 1994; 169:473-475.
24. Chakrabarti S, Brechling K, Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol 1985; 5:3403-3409.
25. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994; 5:976-989.
26. Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary infection. Proc Natl Acad Sci U S A 1997; 94:9848-9853.
27. Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968; 14:181-196.
28. Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995; 96:2311-2321.
29. Choo QL, Kuo C, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis. Science 1989; 244:359-362.
30. Crumpacker DB, Alexander J, Cresswell P, Engelhard VH. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J Immunol 1992; 148:3004-3011.
31. Choi J, Xu Z, Ou J H. Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol Cell Biol 2003; 23:1489-1497.
32. Boulant S, Becchi M, Penin F, Lavergne JP. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 2003; 278:45785-45792.
33. He XS, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, et al. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999; 96:5692-5697.
34. Walewski JL, Gutierrez JA, Branch-Elliman W, Stump DD, Keller TR, Rodriguez A, et al. Mutation master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA 2002; 8:557-571.
35. Wang H, Bian T, Merrill SJ, Eckels DD. Sequence variation in the gene encoding the nonstructural 3 protein of hepatitis C virus: evidence for immune selection. J Mol Evol 2002; 54:465-473.
36. Weiner A, Erickson AL, Kansopon J, Crawford K, Muchmore E, Hughes AL, et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc Natl Acad Sci U S A 1995; 92:2755-2759.
37. Yewdell JW, Del Val M. Immunodominance in TCD8+ responses to viruses: cell biology, cellular immunology, and mathematical models. Immunity 2004; 21:149-153.